Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis Associated With Acute Necrotizing Soft Tissue Infections, The NASTI HAT Trial

NCT05157360 is registered in ClinicalTrials.gov with Ascension Health as lead sponsor.

NCT NCT05157360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis Associated With Acute Necrotizing Soft Tissue Infections, The NASTI HAT Trial
Lead sponsor
Ascension Health
Phase
Phase 1/2
Overall status
Terminated
Start date
September 10, 2021
Completion date
May 16, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing soft tissue infection, sepsis